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Age-Dependent Emergence and Progression
of a Tauopathy in Transgenic Mice Overexpressing
the Shortest Human Tau Isoform
in the adult human CNS (Goedert et al., 1989; Andreadis
et al., 1992) and are localized predominantly in axons
(Binder et al., 1985). Tau proteins bind to MTs and stabi-
lize MTs in the polymerized state (Weingarten et al.,
1975; Drechsel et al., 1992), but the formation of PHF-
Takeshi Ishihara,* Ming Hong,* Bin Zhang,*
Yasushi Nakagawa,* Michael K. Lee,²
John Q. Trojanowski,* and Virginia M.-Y. Lee*³
*The Center for Neurodegenerative Disease Research
Department of Pathology and Laboratory Medicine
tau results in a loss of these important functions (Bram-The University of Pennsylvania School of Medicine
blett et al., 1993; Yoshida and Ihara, 1993). Moreover,Philadelphia, Pennsylvania 19104
unlike normal tau, PHF-tau is insoluble, accumulates in²The Laboratory of Neuropathology
the somatodendritic domain of neurons, and assemblesThe Johns Hopkins School of Medicine
into filaments that aggregate as neurofibrillary tanglesBaltimore, Maryland 21205
(NFTs; Lee et al., 1991; Goedert et al., 1997). In addition
to PHF-tau, other cytoskeletal proteins, such as neuro-
filament (NF) subunits and ubiquitin, are also found inSummary
many NFTs (Perry et al., 1985; Schmidt et al., 1990).
The massive degeneration of neurons and extensiveFilamentous tau aggregates are hallmarks of tauop-
gliosis associated with the progressive accumulation ofathies, e.g., frontotemporal dementia with parkinsonism
PHF-tau lesions provide circumstantial evidence impli-linked to chromosome 17 (FTDP-17) and amyotrophic
cating filamentous tau pathology in the onset/progres-lateral sclerosis/parkinsonism±dementia complex (ALS/
sion of neurodegenerative disease. However, the dis-PDC). Since FTDP-17 tau gene mutations alter levels/
covery of multiple pathogenic mutations in the tau genefunctions of tau, we overexpressed the smallest hu-
of several FTDP-17 families provided direct unequivocalman tau isoform in the CNS of transgenic (Tg) mice to
evidence that tau abnormalities cause neurodegenera-model tauopathies. These mice acquired age-depen-
tive disease. The FTDP-17 mutations (i.e., missense sub-dent CNS pathology similar to FTDP-17 and ALS/PDC,
stitutions, in-frame deletion, intronic substitutions) oc-including insoluble, hyperphosphorylated tau and ar-
cur in exons and introns of the tau gene (Clark et al.,gyrophilic intraneuronal inclusions formed by tau-immu-
1998; Hutton et al., 1998; Iijima et al., 1999; Poorkaj etnoreactive filaments. Inclusions were present in corti-
al., 1998; Spillantini et al., 1998b; D'Souza et al., 1999;cal and brainstem neurons but were most abundant
Rizzu et al., 1999), and they may cause FTDP-17 byin spinal cord neurons, where they were associated
altering the functions or levels of specific tau isoformswith axon degeneration, diminished microtubules (MTs),
in the CNS (Hong et al., 1998; Hutton et al., 1998;and reduced axonal transport in ventral roots, as well
D'Souza et al., 1999). For example, intronic substitutions
as spinal cord gliosis and motor weakness. These Tg
and some missense mutations alter splicing and in-
mice recapitulate key features of tauopathies and pro- crease mRNAs that encode four MT-binding repeat tau
vide models for elucidating mechanisms underlying (4R-tau), as well as the corresponding proteins in the
diverse tauopathies, including Alzheimer's disease (AD). CNS, and this is associated with the selective aggrega-
tion of 4R-tau into filamentous inclusions and the degen-
eration of affected brain regions (Hong et al., 1998;Introduction
D'Souza et al., 1999). Thus, we hypothesize that neuro-
degenerative disease can result from altered expression
Tau is an abundant microtubule- (MT-) associated pro-
levels of normal tau isoforms.
tein in the CNS that is implicated in the pathogenesis To test this hypothesis, we generated transgenic (Tg)
of Alzheimer's disease (AD) and a group of neurodegen- mice that overexpressed the shortest human brain tau
erative diseases known as ªtauopathiesº (Goedert et isoform (ªfetal tauº) in CNS neurons, and we report that
al., 1997). Prototypical tauopathies are exemplified by these Tg mice develop progressive age-dependent ac-
frontotemporal dementia with parkinsonism linked to cumulations of intraneuronal filamentous inclusions, ac-
chromosome 17 (FTDP-17), amyotrophic lateral sclero- companied by neurodegeneration, gliosis, and tau pro-
sis/parkinsonism±dementia complex (ALS/PDC), and tein abnormalities. Since overexpression of normal tau
progressive supranuclear palsy (PSP). Like other tauop- in these Tg mice causes a neurodegenerative disease
athies, FTDP-17, PSP, and ALS/PDC are characterized that partially recapitulates human tauopathies, these
by numerous intraneuronal inclusions formed by aggre- mice will be useful in studies to elucidate mechanisms
gated paired helical filaments (PHFs) and/or straight fila- of brain degeneration in tauopathies.
ments composed of aberrantly phosphorylated tau pro-
teins (PHF-tau) in widespread regions of the brain and Results
spinal cord (Hirano et al., 1961; Tomonaga, 1977; Kato
et al., 1986; Matsumoto et al., 1990; Reed et al., 1998; Generation of Tg Mice that Overexpress
Spillantini et al., 1998a). the Shortest Human Tau Isoform
Six alternatively spliced tau isoforms are expressed To generate Tg mice expressing human tau, a cDNA
corresponding to the shortest human brain tau isoform
(T44, also known as fetal tau) was cloned into an expres-³ To whom correspondence should be addressed (e-mail: vmylee@
mail.med.upenn.edu). sion plasmid, MoPrP.Xho, containing the promoter as
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Figure 1. Tg Mice Expressing the Shortest
Human Brain Tau Generated with the Murine
PrP Promoter
(A) Schematic showing structure of the cDNA
transgene used to make tau Tg mice (not
drawn to scale). Numbered boxes represent
exons contained in the human fetal tau cDNA
(T44 or fetal tau).
(B) Southern blot analysis of the transgene in
Tg mice from lines 7, 43, and 27 by probing
SstI-digested tail DNA with a 1.8 kb BamHI±
KpnI T44 fragment. Semiquantitatively, line
27 has the highest transgene level, and line
7 has the lowest.
(C) Western blot analysis of tau expression in
the cortices of Tg mice. Dephosphorylated
(1) and nondephosphorylated (2) samples,
along with a mixture of six recombinant hu-
man tau proteins, were resolved on 7.5% SDS±PAGE and blotted with T14 and 17026. Equal amounts of total protein (15 mg) were loaded
for the Tg mice (line 7 and line 43, 3 months old; line 27, 9 weeks old), and 135 mg was loaded for the wt mouse (3 months old). The
overexpression levels in each line were calculated by quantitating the nondephosphorylated tau bands recognized by 17026.
(D) Western blot analysis of regional expression of tau in the cerebral cortex (Cx), hippocampus (Hip), brainstem (Bs), cerebellum (Cb), and
spinal cord (SC) of line 7 Tg and wt mice (6 months old). Equal amounts (15 mg) of mouse samples and an aliquot of autopsy-derived human
fetal tau were loaded on each gel.
well as 59 intronic and 39 untranslated sequences of the Tau Tg Mice Acquire CNS Tau Inclusions Similar
to Human Tauopathiesmurine prion protein (PrP) gene (Figure 1A). This vector
was used here because it enables relatively high levels Tg mice and their wt littermates from lines 7 and 43,
between 1 and 12 months of age, were subjected toof transgene expression in CNS neurons (Borchelt et al.,
1996). Tg mice were identified by Southern blot analysis histological studies. Paraffin-embedded coronal brain
sections and transverse spinal cord sections wereusing a human T44 cDNA probe, which detected the
transgene as a 3.1 kb band from SstI-digested genomic stained with T14 to determine the regional and cellular
distribution of Tg tau. These studies demonstrated wide-DNA obtained from tail samples (Figures 1A and 1B).
Three stable Tg lines were established that variably spread expression of human tau in neurons and their
processes throughout the CNS of the Tg but not the wtoverexpressed human tau, as demonstrated by quanti-
tative Western blot analysis of whole-brain extracts from mice, and the intensity of tau immunoreactivity in the Tg
mice remained constant at all ages examined (Figures 2heterozygous Tg mice. Figure 1C illustrates representa-
tive Western blots produced by loading equal amounts and 3).
In Tg mouse spinal cords, T14-positive spheroidal in-of total protein from Tg mice and 9-fold more protein
from a wild-type (wt) littermate control, before and after traneuronal inclusions were observed at 1 month, and
the size and number of these inclusions increased fordephosphorylation, into adjacent lanes of a gel followed
by electrophoresis and protein transfer to blot mem- up to 6±9 months, but they decreased in abundance
by 12 months (Figures 2A±2C). Notably, many vacuolarbranes. These data show that tau proteins from all three
Tg mouse lines, but not from the wt mouse, are detected lesions of the same size or larger than the inclusions
were also observed in the older Tg mice (Figure 2C),by T14, a human tau-specific monoclonal antibody
(mAb), and that the dephosphorylated tau bands from which may reflect the degeneration of affected axons.
The inclusions were about the size of medium-to-largethe Tg mice align with recombinant fetal human tau.
Using a polyclonal antibody (17026) that recognizes hu- spinal cord neurons, and some appeared to arise within
proximal axons of spinal cord neurons. Although theyman and mouse tau in quantitative Western blot studies,
we showed that the heterozygous Tg mouse lines 7, 43, occurred in gray and white matter at all spinal cord
levels, the inclusions were most frequent at the gray±and 27 overexpressed tau proteins at levels that were
approximately 5-, 10-, and 15-fold higher, respectively, white junction.
Spinal cord sections were probed with a panel ofthan endogenous mouse tau. Figure 1D demonstrates
that the expression levels of Tg tau varied in different antibodies to tau and other neuronal cytoskeletal pro-
teins, and the inclusions were immunostained by anCNS regions, as revealed by Western blot studies con-
ducted on Tg line 7 with antibodies T14 and 17026. antibody commonly used to detect tau protein found in
PHFs (i.e., Alz50; Figure 2D) and other hyperphosphory-For example, neocortex, hippocampus, brainstem, and
cerebellum express comparable levels of Tg tau, but lated PHF-tau epitopes, including PHF1 (phosphoserine
396 and 404, numbering according to the largest humanspinal cord expresses z60% of those seen in these
regions. brain tau), PHF6 (phosphothreonine 231), T3P (phospho-
serine 396), AT8 (phosphoserine 202 and 205), AT270Although the heterozygous line 27 mice had the high-
est levels of Tg tau, they were not viable beyond 3 (phosphothreonine 181), and 12E8 (phosphoserine 262)
(data not shown). Therefore, these lesions contain hy-months, and homozygous mice generated from each of
the three lines died in utero or within 3 months postnatal. perphosphorylated tau similar to PHF-tau. Significantly,
these inclusions were also stained strongly with antibod-Therefore, the studies described below were conducted
on 1- to 12-month-old heterozygous Tg mice from lines ies to the low- (NFL), middle- (NFM), and high- (NFH)
molecular mass NF proteins (Figures 2F±2H and 2K).7 and 43.
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Figure 2. Tau Tg Mice Developed Tau-Rich Inclusions in the Spinal Cord
(A±C) Spheroidal intraneuronal inclusions in spinal cord sections of 1-, 6-, and 12-month-old Tg mice stained with T14, which appeared as
early as 1 month of age (arrows) and peaked at 6±9 months but decreased at 12 months.
(D±I) The inclusions were stained positive with Alz50 (D), a-tubulin (E), and antibodies against NF proteins (F±H), as well as by Bodian silver
method (I). The inclusions seen in line 43 Tg mice (H) were larger in size and appeared earlier than those in line 7.
(J±L) Double-labeled indirect immunofluorescence of the spinal cord inclusions from a 6-month-old Tg mouse. Green, 17026 (J); red, RMdO9
(K); and double channels (L).
Scale bar, 100 mm (A±H); 10 mm ([B], inset); 30 mm (I); and 10 mm (J±L).
Both phosphorylated and nonphosphorylated NFM and RMdO9 confirmed the colocalization of tau and NFs in
these inclusions (Figures 2J±2L). In addition, anti-tubulinNFH were observed in these lesions. Indirect immunoflu-
orescence double labeling with antibodies 17026 and antibodies immunostained these inclusions (Figure 2E).
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Figure 3. Tau Tg Mice Developed Tau-Rich
Inclusions in Cortical and Brainstem Neurons
Cerebral cortices of 6-month-old wt (A) and
Tg (B) mice stained with T14. Arrows in (B)
indicate small, tau-positive intraneuronal le-
sions. Similar lesions were also observed in
pontine neurons of Tg mice (C). The cortical
lesions occurred either in proximal axons (D)
or in somatodendritic domains (E) of neurons.
Brainstem inclusions are also stained by the
Bodian silver method (F). Scale bar, 100 mm
(A±C); 20 mm (D and E); and 30 mm (F).
In the brains of the Tg mice, tau-positive intraneuronal mm in diameter, and some inclusions almost completely
filled the axon. Mitochondria were trapped within oc-aggregates were also detected, but they were smaller
and appeared later than the spinal cord inclusions. They casional aggregates (Figure 4C). Immuno-EM studies
showed that the filaments were immunolabeled by anti-were first seen in the pontine neurons of 1-month-old
animals and emerged in the cerebral cortex at about bodies to tau, NFs, and tubulin (Figures 4D±4F).
Since the argyrophilic filamentous lesions of our Tg6 months of age (Figure 3). The immunohistochemical
profile of these brain aggregates was similar to that of mice are concentrated in the spinal cord and brainstem,
and since tau-positive NFTs and dystrophic neurites arethe spinal cord lesions, i.e., they contained hyperphos-
phorylated tau, all three NF subunits, and tubulin epi- found in the spinal cord of some ALS/PDC patients and
in the brainstem of PSP and FTDP-17 patients, we di-topes (data not shown). However, the morphological
features of these inclusions indicates that some are vari- rectly compared the tau inclusions in spinal cord of ALS/
PDC and brainstems of PSP and FDTP-17 with those inants of the spinal cord axonal lesions (Figure 3D), but
others occur in the somatodentritic compartment of cor- our Tg mice, and we found that they were similar (see
Figures 5A±5D, and compare Figures 3C±3E with Fig-tical neurons and resemble NFTs and dystrophic neu-
rites (Figure 3E). Notably, the brain and spinal cord inclu- ures 5B±5D). Significantly, in the ALS/PDC spinal cord,
NF immunoreactivity colocalized with tau in many of thesions were positively stained by the Bodian silver
method (Figures 2I and 3F), similar to human NFTs, but inclusions (compare Figures 5E±5G with Figures 2J±2L).
These data, taken together with the findings describedwere thioflavine S negative, and they were not stained
by antibodies to a-internexin, peripherin, ubiquitin, or above, suggest that these tau Tg mice develop a neuro-
degenerative disease that recapitulates the hallmark le-synucleins (data not shown).
Line 43 expressed higher levels of human tau than sions of human tauopathies.
line 7, and similar tau-rich inclusions were also observed
in the spinal cord and the brain in an age-dependent Insoluble Tau Protein Progressively Accumulates
in the CNS of Tau Tg Micemanner (Figure 2H), but they were larger and more abun-
dant than in line 7. For example, we found that in the To determine whether tau became insoluble in the tau
Tg mice with age and disease progression, as in humanspinal cord of 6-month-old animals, line 43 expresses
twice as many tau inclusions as line 7. These results tauopathies, we analyzed the solubility of tau protein by
extracting brain and spinal cord samples using buffersindicate that the accumulation of these tau-rich lesions
in the tau Tg mice is transgene dose dependent as well with increasing extraction strengths. As shown in Figure
6, the spinal cord and brain samples from 1-, 3-, 6-, andas age dependent.
Transmission electron microscopy (EM) studies of 9-month-old line 7 Tg and wt mice were sequentially
extracted with reassembly buffer (RAB), radioimmuno-these inclusions (Figure 4) revealed masses of tightly
packed aggregates of randomly arranged 10±20 nm precipitation assay (RIPA) buffer, and 70% formic acid
(FA). The three fractions were then analyzed by quantita-straight filaments in the myelinated spinal cord axons
of Tg (Figures 4B and 4C) but not wt (Figure 4A) mice. tive Western blotting with antibody 17026. In the wt
mice, about 90% of endogenous mouse tau in both theThese aggregates were found in ≈30% of myelinated
and unmyelinated axons ranging from 200 nm to 20 brain and the spinal cord was largely RAB-soluble and
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Figure 4. Tau-Rich Inclusions in Proximal
Axons Contained Straight Filaments
(A) NFs evenly distributed in a spinal cord±
myelinated axon of a wt mouse.
(B and C) Masses of tightly packed disorga-
nized filamentous aggregates in a spinal cord
axon of a 6-month-old Tg mouse.
(D±F) Postembedding immuno-EM labeled
the aggregates with T14 (D), NFL (E), and anti-
b-tubulin (F) antibodies. Note that silver en-
hancement was performed for T14 staining.
Scale bar, 500 nm (A and B); 300 nm (C); and
200 nm (D±F).
no immunoreactivity was detected in the FA-soluble PHF-tau, we performed Western blot analysis of soluble
and insoluble tau extracted from the cerebral cortex offraction. In the Tg mice, although the RAB-soluble tau
remained relatively constant at around 75%±80% with Tg mice. As shown in Figure 7, phosphorylation-inde-
pendent antibody 17026 recognized human PHF-tau,increasing age, RAB-insoluble tau represented by the
RIPA and FA fractions progressively accumulated in adult normal tau, and fetal tau, as well as both soluble
and insoluble mouse endogenous tau and Tg tau. Simi-both the brain and the spinal cord. For example, RIPA-
soluble tau in brain increased from about 17% at 1 month larly, T14 recognized all but the mouse tau sample. mAb
to about 25% at 9 months, and FA-soluble tau in spinal T1 (specific for a tau epitope that is not phosphorylated
cord increased from about 0.4% to about 1.8% over the at amino acids 189±207) did not recognize PHF-tau but
same time period. The accumulated RAB-insoluble tau was immunoreactive with human adult normal tau, fetal
was mainly Tg tau, and the time course of accumulation tau, and both soluble and insoluble Tg tau. This indicates
correlated with the emergence of tau pathology in the that tau from the Tg mice is partially dephosphorylated
Tg mice. In addition, RAB-insoluble tau, especially the at the T1 epitope. However, several phosphorylation-
FA fraction, was more pronounced in spinal cord than dependent antibodies that reacted with PHF-tau and
brain, consistent with more abundant tau aggregates in fetal tau, but not with normal adult tau, also recognized
the spinal cord. both soluble and insoluble tau from the Tg mice. These
antibodies include PHF1 (phosphoserine 396 and 404),
T3P (phosphoserine 396), PHF6 (phosphothreonine 231),The Phosphorylation State of Tau in Tg Mice
AT8 (phosphoserine 202 and 205), AT270 (phosphothreo-Recapitulates that of PHF-Tau
nine 181), and 12E8 (phosphoserine 262). Therefore, theTo determine whether tau proteins in tau Tg mice pos-
sessed the same hyperphosphorylated epitopes as phosphorylation state of Tg tau recapitulates that of
Neuron
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Figure 5. Neurofibrillary Lesions in Brainstem and Spinal Cord of Neurodegenerative Tauopathies
(A±D) Numerous neurofibrillary lesions in brainstem sections stained with PHF1 in a PSP (A) and T3P in an FTDP-17 with the P301L tau
mutation (B) case. Tau-positive dystrophic neurites (C) and NFTs (D) also were stained with 17026 on a spinal cord section of ALS/PDC.
(E±G) Double-labeled indirect immunofluorescence with antibodies 17026 and TA51 indicated the colocalization of tau and NF epitopes in
the spinal cord lesions of ALS/PDC.
Scale bar, 40 mm (A and B); 20 mm (C and D); and 10 mm (E±G).
PHF-tau found in human tauopathies and human fetal fibrillary acidic protein (GFAP) to detect astrocytosis
reactive to neuronal damage. In the Tg but not the wttau but is different from that of normal adult human tau.
mice, numerous reactive astrocytes were immunostained
in both the brain and the spinal cord (data not shown),Tau Tg Mice Develop Profound Astrocytosis,
Reduced Fast Axonal Transport, and Progressive indicative of profound gliosis and neuronal damage. Fur-
ther, the astrocytosis was almost undetectable at 1Motor Weakness Contemporaneous
with Axonal Degeneration month of age but progressed thereafter with age.
Since inclusions in the proximal axons of affectedTo examine the pathological consequences of the accu-
mulation of hyperphosphorylated tau as filamentous ag- neurons could cause disease by damaging axons, we
examined the morphology of spinal cord ventral rootgregates in the CNS of the tau Tg mice, brain and spinal
cord sections were stained with a mAb specific for glial axons. In Figure 8A, semithin section micrographs show
Figure 6. Insoluble Tau Protein Progressively
Accumulated in the CNS of Tau Tg Mice
Neocortical and spinal cord tissues of 1-, 3-,
6-, and 9-month-old Tg and wt mice were
sequentially extracted with RAB Hi-Salt, RIPA
buffer, and 70% FA, and the tau levels were
determined by quantitative Western blot analy-
sis with 17026. RAB-insoluble tau, repre-
sented by the RIPA and FA fractions, progres-
sively accumulated in both the brain and the
spinal cord of the Tg mice but not in the wt
mice.
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Figure 7. The Phosphorylation State of Tg
Tau Recapitulated that of PHF-Tau
AD PHF-tau, autopsy-derived normal human
adult tau, and autopsy-derived human fetal
tau samples were run along with neocortical
soluble and insoluble tau from a 6-month-old
Tg mouse. Antibodies 17026 and T14 reacted
with tau proteins, regardless of phosphoryla-
tion. Non-phosphorylation-dependent anti-
body T1 did not recognize PHF-tau. Phos-
phorylation-dependent antibodies PHF1, T3P,
AT8, AT270, and 12E8 did not react with nor-
mal adult tau but recognized PHF-tau and
fetal tau, as well as both soluble and insoluble
tau from the Tg mouse.
the normal lumbar 5 (L5) ventral root of wt mouse, con- and at 12 months of age, the endoneurial space ap-
peared to increase (Figure 8C), consistent with the re-taining many large- and small-sized myelinated axons.
By contrast, the ventral root of a 6-month-old Tg mouse moval of degenerated axons in these nerves. Evidence
of axonal degeneration also came from comparing axonprimarily contained irregularly shaped axons (Figure 8B),
Figure 8. Axonal Degeneration in the Spinal Cord Ventral Roots and Reduction of Axonal MTs in Tau Tg Mice
A semithin section micrograph shows the L5 ventral root of a 6-month-old wt mouse, which contains many large- and small-sized myelinated
axons tightly packed and evenly distributed (A). In 6-month-old Tg mice, the ventral root axons are irregularly shaped (B), and by 12 months
of age a prominent endoneurial space is found in Tg mice (C). MTs (arrow) and NFs (arrowhead) in the ventral root axons were visualized by
EM micrographs (D±F). Quantification of ventral root axon numbers demonstrates a 20% reduction (n 5 3) in the Tg mice relative to their wt
littermates (G). A significant reduction in the MT density was observed in the 12-month-old Tg mice (H), and there was no significant difference
in NF density in the Tg mice relative to the wt mice (I). Scale bar, 20 mm (A) and 200 nm (B). Double asterisk, p , 0.01.
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Figure 9. Tubulin Level Was Decreased in the Sciatic Nerve of Tau Tg Mice
Western blots showing tau (A), NF (B), and b-tubulin (C) levels in the sciatic nerve of 1-, 3-, 6-, and 9-month-old wt and Tg mice. The Tg tau
levels (A) were comparable in different ages. Note the peripheral nervous system tau isoform (ªbig tauº) as the upper bands in the tau blot
(A). There was no significant difference in the NF protein level in the Tg mice relative to the wt mice (B). However, a progressive decrease in
b-tubulin levels was detected in the Tg mice but not in the wt mice (C and D); n 5 3; asterisk, p , 0.05; double asterisk, p , 0.01.
numbers in L5 ventral roots of Tg and wt mice, based Discussion
on semithin section micrographs. Although at 6 months
Our study provides compelling evidence that the overex-of age the number of axons in the Tg mice was compara-
pression of normal tau protein in Tg mice causes a CNSble to that measured in of age-matched wt mice, a 20%
neurodegenerative tauopathy that recapitulates key as-decrease was seen in 12-month-old Tg mice, relative to
pects of human tauopathies, such as ALS/PDC and PSP,their wt counterparts (Figure 8G). We also determined
as well as some FTDP-17 syndromes. For example, wethe densities of NFs and MTs in the L5 ventral root axons
observed a progressive, age-dependent accumulationin these mice (Figures 8D±8F). Interestingly, despite a
of argyrophilic, tau-immunoreactive inclusions in neu-significant reduction of MT density in the 12-month-
rons of spinal cord, brainstem, and neocortex, similarold Tg mice, the NF density remained unchanged when
to human tauopathies. Since the inclusions in the Tgcompared with age-matched wt mice (Figures 8H±8I).
mice were most abundant in spinal cord neurons, theThis finding correlated with the biochemical analysis of
tauopathy in these mice most closely resembles ALS/b-tubulin and NF subunits in the proximal sciatic nerve,
PDC, wherein tangles are abundant in spinal cord neu-which showed a progressive decrease in b-tubulin level
rons (Hirano et al., 1961; Matsumoto et al., 1990). Signifi-in the Tg mice and relatively constant levels of NF sub-
cantly, ALS/PDC patients who present with motor weak-units (Figure 9).
nesses do so about a decade earlier than those whoTo assess whether or not the neuropathology in ven-
present with parkinsonism and dementia. Thus, the ac-tral roots of 12-month-old tau Tg mice compromised
cumulation of tau aggregates in the brains of our Tg miceaxonal transport, we measured radiolabeled proteins
later than in spinal cord mirrors disease progression intransported in the fast component following microinjec-
ALS/PDC patients who present with motor weakness.tion of [35S]methionine into the L5 ventral horn of tau Tg
Moreover, as shown here and reported earlier, these tauand age-matched wt mice, and this showed retarded
fast axonal transport of radiolabeled proteins in the tau tangles also are immunostained by antibodies to NF
proteins and tubulin (Shankar et al., 1989), as are theTG mice (Figure 10A). The greatest differences in the
amounts of transported radiolabeled proteins appeared inclusions in our Tg mice. Finally, ALS/PDC is associated
with a progressive motor weakness similar to that ob-around the 4 mm segment, where almost twice as many
radiolabeled proteins were detected in wt compared served in the Tg mice.
Although the distribution of the tau pathology in ourwith tau TG mice (Figure 10B).
In addition to acquiring the spinal cord pathologies mice most closely resembles that found in ALS/PDC
and PSP, as well as in some FTDP-17 syndromes, thesedescribed above, the tau Tg mice also developed pro-
gressive motor weakness, as demonstrated by their im- filamentous tau aggregates share many characteristics
with authentic NFTs in AD and other tauopathies. First,paired ability to stand on a slanted surface and by retrac-
tion of their hindlimbs when lifted by their tails (data not like highly insoluble PHF-tau, in AD NFTs (Bramblett et
al., 1992) a substantial fraction of tau proteins from theshown). These impairments may explain the fact that
the Tg mice weighed about 30%±40% less than age- Tg mice is extracted only with RIPA and FA, despite the
fact that normal tau is an extremely soluble protein.matched wt littermates.
Neurodegenerative Tauopathy in Tau Tg Mice
759
closely resemble Pick bodies found in Pick's disease,
since Pick bodies are composed almost exclusively of
3R-tau isoforms. One notable difference, however, is
that all three brain 3R-tau isoforms are found in Pick
bodies, whereas only the fetal 3R-tau isoform is present
in the tau aggregates in the Tg mice. Nevertheless, it is
noteworthy that insoluble tau tangles composed of all
six tau isoforms (as seen in AD and ALS/PDC), or pre-
dominantly of 4R-tau isoforms (as detected in PSP) or
3R-tau (as found in Pick's disease), have been reported,
and recent studies of FTDP-17 and other familial tauopa-
thies suggest that tau tangles composed of different
ratios of the six alternatively spliced tau isoforms exist
in different tauopathies (Hong et al., 1998; Hutton et al.,
1998; Spillantini et al., 1998b; D'Souza et al., 1999). Thus,
multiple mechanisms can perturb tau gene function, re-
sulting in the formation of tau tangles with different tau
isoforms.
Since the accumulation of filamentous tau inclusions
in spinal cord neurons was associated with the degener-
ation of ventral root axons in the tau Tg mice, we hypoth-
esize that this reflects a gain of toxic function by the
overexpressed tau, and several lines of evidence sup-
port this hypothesis. First, previously described tau Tg
mice that expressed lower levels (,2-fold) of tau protein
did not develop filamentous tau inclusions or neurode-
generation (Goetz et al., 1995; Brion et al., 1999). Sec-
ond, we observed a Tg tau dose-dependent increase in
the size and number of tau aggregates in our two lines
of Tg mice. Thus, one plausible explanation to account
for the axonal degeneration in these Tg mice is a gain
of toxic function by the excess tau proteins that cannot
bind MTs, aggregate in the neuronal cytoplasm, block
Figure 10. Orthograde Fast Axonal Transport Is Reduced in the Ven- axonal transport, and lead to the degeneration of af-
tral Root Axons of the Tau Tg Mice fected axons.
SDS±PAGE analysis shows retardation in the L5 ventral roots of the The reduced numbers of MTs and the reduced levels
spinal cord in the tau Tg mice compared with wt mice. Fluorograph
of tubulin, but not NFs or NF proteins, in the remaininghighlights a retardation in the fast transport of several proteins
axons of the degenerating ventral roots also imply a(closed diamond, circle, star, and triangle) in the 12-month-old Tg
loss of the MT-stabilizing function of tau. Since our datamice (A). The graph in (B) illustrates quantitative measurements of
showed that the level of endogenous mouse tau (i.e.,proteins conveyed by fast axonal transport in tau Tg and wt mice
(average of six nerves from groups of three animals). The fast trans- only 4R-tau) is not altered in the tau Tg mice, the endoge-
port of several proteins is retarded in the 12-month-old Tg mice nous mouse tau should be sufficient to stabilize MTs in
compared with wt mice (B). Asterisk, p , 0.05. the Tg mice. However, overexpressed human tau could
aggregate with endogenous mouse tau, leading to pro-
gressive insolubility and hyperphosphorylation of both
Second, the amount of insoluble tau protein progres- human and mouse tau in the Tg mice. This could impair
sively accumulates with age and disease progression endogenous mouse tau from performing an MT-stabiliz-
in the Tg mice, similar to AD and other tauopathies. ing function. Indeed, the observed reduction in fast axo-
Third, PHF-tau proteins in human NFTs are hyperphos- nal transport in 12-month-old Tg mice is consistent with
phorylated, and so is soluble and insoluble tau recov- a loss of MT function, although the loss of axons in
ered from Tg mice (Lee et al., 1991; Matsuo et al., 1994). the Tg mice may contribute to this. Based on indirect
Fourth, although AD NFTs contain mostly PHFs, straight evidence from studies of human tauopathies, we and
filaments similar to those found in the inclusions of the others have proposed that both gains of toxic functions
Tg mice are also present (Goedert et al., 1997). Finally, and losses of normal tau functions could be involved
in addition to ALS/PDC, NF protein immunoreactivity mechanistically in causing neurodegenerative disease
also occurs in the NFTs of AD, PSP, and other tauopa- (Hong et al., 1998; Hutton et al., 1998; D'Souza et al.,
thies (Nakazato et al., 1984; Perry et al., 1985; Shankar 1999), and the data presented here support both of these
et al., 1989; Schmidt et al., 1990, 1991). mechanistic hypotheses.
Despite similarities found between the tau aggregates Although a dose effect of the transgene is observed
in our Tg mice and those of other tauopathies, the tau in two different Tg mouse lines, the distribution of the
inclusions in the Tg mice are not identical to AD NFTs, tau-rich lesions within the CNS is not completely depen-
which composed all of six tau isoforms, while the Tg dent upon the expression levels across the different
tau proteins do not contain all six tau isoforms. In this regions. For example, spinal cord expresses less Tg tau
than brain, but more abundant and larger inclusionsregard, the filamentous Tg tau inclusions perhaps more
Neuron
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being lethally anesthetized. The brains and spinal cords were re-accumulate earlier in spinal cord neurons than in the
moved and continuously fixed overnight by immersion in 70% iso-other brain regions. This could be explained by the meta-
tonic ethanol. Paraffin-embedded sections were prepared andbolic differences among diverse types of neurons, and
probed by immunohistochemistry as described (Tu et al., 1995).
excess tau may aggregate at a lower concentration in Double-label indirect immunofluorescence was performed with anti-
spinal cord neurons under the influence of local factors tau and anti-NF antibodies and detected by FITC-conjugated don-
key anti-rabbit IgG and Texas Red±conjugated donkey anti-mouseor chaperones, such as high concentrations of NF pro-
IgG (Jackson Laboratories), respectively. Hematoxylin and eosin,teins. Similarly, the selective distribution of tau pathol-
thioflavine S, and Bodian silver staining methods also were usedogy in different human tauopathies is likely due to other
to characterize the neuropathology in Tg and wt mice. Light andas yet unidentified local vulnerability factors. Indeed,
fluorescent microscopy were performed with a Nikon Microphot-
the findings described here parallel the well-known but FXA microscope system. At least three Tg and one wt mice were
enigmatic ªselective vulnerabilityº that is a constant fea- examined at each time point of 1, 3, 6, 9, and 12 months. Human
tissue blocks from PSP, FTDP-17, and ALS/PDC cases were cutture of most human neurodegenerative diseases and Tg
and stained as described above.mouse models thereof (Tu et al., 1997). Similar to all
animal models of human diseases, the Tg tau mice de-
Tau Protein Solubility in the CNS of Tg Micescribed here do not fully recapitulate every feature of a
To study the solubility of tau proteins in the mouse CNS, cerebralhuman neurodegenerative tauopathy, but this Tg model
cortical and spinal cord tissues of 1-, 3-, 6-, and 9-month Tg and
exhibits the key neuropathological features that define wt mice were extracted with RAB Hi-Salt to generate the RAB-
this class of CNS disorders. Therefore, these mice will soluble fractions as described above. The pellets were rehomog-
enized with 1 M sucrose/RAB (0.1 M MES, 1 mM EGTA, and 0.5 mMbe useful in studies designed to further elucidate mecha-
MgSO4 [pH 7.0]) and centrifuged at 50,000 3 g for 20 min at 48C.nisms leading to the formation of tau pathology and
The resulting pellets were extracted with 1 ml/g RIPA buffer (50 mMthe selective degeneration of neurons in FTDP-17, PSP,
Tris, 150 mM NaCl, 1% NP40, 5 mM EDTA, 0.5% sodium deoxycho-ALS/PDC, AD, Pick's disease, and related tauopathies.
late, and 0.1% SDS [pH 8.0]) and centrifuged to generate RIPA-
soluble samples, the RIPA-insoluble pellets were reextracted with
70% FA, and quantitative Western blots were used to determine
Experimental Procedures tau level in each fraction.
Generation of Tau Tg Mice
Determination of the Phosphorylation State of Tau in Tg Mice
A cDNA construct of the shortest human brain tau isoform (T44)
To assess the phosphorylation state of Tg tau, cortical tissues from
was cloned into the MoPrP.Xho expression vector at the XhoI site.
6-month-old line 7 Tg mice were extracted as described above.
A 15 kb NotI fragment containing T44, the PrP promoter, together
A simplified protocol was adopted to generate the RAB-insoluble
with its 39 untranslated sequences, was used as the transgene to
fractions. Briefly, the RAB-insoluble pellets were sonicated in sam-
create tau Tg mice on a B6D2/F1 background. Genomic DNA sam-
ple buffer containing 0.2 g/ml sucrose, 18.5 mM Tris (pH 6.8), 2 mM
ples were isolated from mouse tails with the Puregene (Gentra Sys-
EDTA, 80 mM DTT, and 2% SDS, and the 50,000 3 g supernatants
tems) DNA isolation kit. Potential founders were identified by South-
were used as insoluble Tg tau samples. Human PHF-tau, autopsy-
ern blot analysis with a 32P-labeled T44 probe. Three stable Tg lines
derived adult tau, and fetal tau were prepared as described (Lee et
(lines 7, 27, and 43) were established, and Tg and wt offspring were
al., 1991; Bramblett et al., 1992, 1993).
identified by Southern blot analysis of tail DNA.
Determination of Tubulin and NF Protein Levels in Sciatic
Nerves of Tg MiceWestern Blot Analysis of Tau Expressed in the CNS
To determine the tubulin and NF protein levels in sciatic nerves, 10of wt and Tg Mice
mm segments of proximal sciatic nerve from line 7 Tg mice andTo estimate tau expression levels in different Tg lines and in the
age-matched wt mice (1, 3, 6, and 9 months) were harvested anddiverse CNS regions of line 7 Tg mice, tissues were carefully dis-
individually homogenized in 500 ml of ice-cold RAB Hi-Salt buffer.sected after mice were lethally anesthetized. The tissues were ho-
After centrifugation at 50,000 3 g for 40 min at 48C, the supernatantsmogenized in 2 ml/g of ice-cold RAB Hi-Salt buffer (0.1 M morpholi-
were used for the analysis of tau and tubulin, whereas the pelletsneethanesulfonic acid (MES), 1 mM EGTA, 0.5 mM MgSO4, 0.75 M
were used for NF analysis. Equal volumes (15 ml) of each sample wereNaCl, 0.02 M NaF, 1 mM phenylmethylsulfonyl fluoride, and 0.1%
analyzed by quantitative Western blotting.protease inhibitor cocktail [100 mg/ml each of pepstatin A, leupeptin,
N-tosyl-L-phenylalanyl chloromethyl ketone, N-tosyl-lysine chlo-
Electron Microscopyromethyl ketone, and soybean trypsin inhibitor, and 100 mM EDTA
Transmission EM was performed to study the ultrastructure of the(pH 7.0)]) and centrifuged at 50,000 3 g for 40 min at 48C in the
inclusions. Tg mice and wt littermates at 6 and 12 months of ageBeckman TL-100 ultracentrifuge. The supernatants were boiled for
(n 5 4) were deeply anesthetized and sacrificed by intracardiac5 min, chilled on ice for 5 min, and recentrifuged at 10,000 3 g for
perfusion with 10 ml of 0.1 M cacodylate buffer (pH 7.4) followed20 min at 48C. Protein concentration was then determined for the
by 50 ml fixative (2% glutaraldehyde and 2% paraformaldehyde insecond supernatants with the BCA assay kit (Pierce). To prepare
0.1 M cacodylate buffer). The L5 segments of the spinal cord anddephosphorylated tau, an aliquot of the supernatant was incubated
L5 ventral roots were removed and postfixed in 2% osmium tetrox-with Escherichia coli alkaline phosphatase (Sigma) at 378C overnight
ide for 45 min at 48C. The samples were embedded, sectioned,as described (Hong et al., 1998). Equal amounts (15 mg) of nonde-
stained, and examined as described (Tu et al., 1995).phosphorylated and dephosphorylated samples were subsequently
Postembedding immuno-EM was performed for Tg and wt miceresolved on 7.5% SDS±PAGE gels and transferred onto nitrocellu-
(6 and 12 months, n 5 4) by intracardiac perfusion with 10 ml of 0.1lose membranes. Quantitative Western blot was performed by using
M cacodylate buffer (pH 7.4) and 50 ml of fixative (0.2% glutaralde-125I-labeled goat anti-mouse immunoglobulin G (IgG) or 125I-labeled
hyde, 2% paraformaldehyde, and 0.2% pricric in 0.1 M cacodylateProtein A (NEN) as secondary antibodies. Recombinant proteins of
buffer) followed by postfixation in fixative containing 0.2% glutaral-the six human brain tau isoforms and human fetal tau were made
dehyde, 4% paraformaldehyde, 0.2% pricric, and 0.1 M cacodylateas previously described (Goedert and Jakes, 1990).
overnight. The tissue blocks were quenched in 0.1 M Tris and 1 M
glycine for 15 min, dehydrated with graded ethanol, and then infil-
trated and embedded in LR-White resin (London Resin). Grids withImmunohistochemical and Histochemical Studies
Animals were perfused transcardially with 15 ml of phosphate-buf- ultrathin sections were blocked in PBS containing 5% donor horse
serum and 0.2% cold water fish skin gelatin and incubated withfered saline (PBS) followed by 15 ml of 70% isotonic ethanol after
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primary antibodies overnight at 48C. Goat anti-mouse nanogold-IgG selective reduction in levels of binding-competent tau and accumu-
lation of abnormal tau-isoforms (A68 proteins). Lab. Invest. 66,(for T14 and b-tubulin) or goat anti-rabbit nanogold-IgG (for NFL)
(Nanoprobes) was used as secondary antibody. 212±222.
Bramblett, G.T., Goedert, M., Jakes, R., Merrick, S.E., Trojanowski,
Quantification of Axon Number, MT Density, and NF Density J.Q., and Lee, V.M.-Y. (1993). Abnormal tau phosphorylation at
in Ventral Roots Ser396 in Alzheimer's disease recapitulates development and con-
The toluidine blue±stained semithin sections were used to count tributes to reduced microtubule binding. Neuron 10, 1089±1099.
axon numbers in the L5 ventral roots of 6- and 12-month-old Tg Brion, J.-P., Tremp, G., and Octave, J.-N. (1999). Transgenic expres-
and wt mice prepared for transmission EM (n 5 3). To quantitate sion of the shortest human tau affects its compartmentalization and
MTs and NFs, ten transversely sectioned axons from each ventral its phosphorylation as in the pretangle stage of Alzheimer's disease.
root were randomly chosen and photographed at 25,0003 magnifi- Am. J. Pathol. 154, 255±270.
cation by transmission EM. A template transparency containing
Carmel, G., Mager, E.M., Binder, L.I., and Kuret, J. (1996). The struc-
identical hexagons with a defined area was overlaid on the micro-
tural basis of monoclonal antibody Alz50's selectivity for Alzheimer's
graphs, and the number of MTs and NFs in each hexagon was
disease pathology. J. Biol. Chem. 271, 32789±32795.
counted to generate MT and NT densities per unit area. The results
Clark, L.N., Poorkaj, P., Wszolek, Z.K., Geschwind, D.H., Nasreddine,were analyzed by Student's t test.
Z.S., Miller, B., Payami, H., Awert, F., Markopoulou, K., D'Souza, I.,
et al. (1998). Pathogenic implications of mutations in the tau geneFast Axonal Transport Studies
in pallido-ponto-nigral degeneration and related chromosome 17±Twelve-month-old tau TG and age-matched mice (n 5 3 per group)
linked neurodegenerative disorders. Proc. Natl. Acad. Sci. USA 95,underwent laminectomy from segments T13 to L1 of the spinal cord
13103±13109.under deep anesthesia. [35S]methionine (300 mCi) in 0.8 ml of saline
Drechsel, D.N., Hyman, A.A., Cobb, M.H., and Kirschner, M.W.was microinjected into two sites of each side of the L5 ventral horn
(1992). Modulation of the dynamic instability of tubulin assembly bywith a stereotaxic apparatus over a period of 5 min as previously
the microtubule-associated protein tau. Mol. Biol. Cell 3, 1141±1154.described (Zhang et al., 1997). Animals were sacrificed 3 hr after
microinjection, and the L5 ventral roots were removed, cut into five D'Souza, I., Poorkaj, P., Hong, M., Nochlin, D., Lee, V.M.-Y., Bird,
T.D., and Schellenberg, G.D. (1999). Missense and silent tau geneconsecutive segments of 2 mm length (from proximal to distal),
processed for SDS±PAGE, and subjected to quantitative Western mutations cause frontotemporal dementia with parkinsonism - chro-
mosome 17 type, by affecting multiple alternative RNA splicing regu-blotting to assess fast axonal protein transport.
latory elements. Proc. Natl. Acad. Sci. USA 96, 5598±5603.
Antibodies Goedert, M., and Jakes, R. (1990). Expression of separate isoforms
The following antibodies were used in this study: T14 (a mAb specific of human tau protein: correlation with the tau pattern in brain and
to human tau), 17026 (a rabbit polyclonal antibody made against effects on tubulin polymerization. EMBO J. 9, 4225±4230.
the largest human recombinant tau), and Alz50 (a mAb specific for Goedert, M., Spillantini, M.G., Jakes, R., Rutherford, D., and
a conformation epitope found in PHFs), which are phosphorylation Crowther, R.A. (1989). Multiple isoforms of human microtubule±
independent antibodies (Kosik et al., 1988; Trojanowski et al., 1989; associated protein tau: sequences and localization in neurofibrillary
Carmel et al., 1996); mAb T1 (Binder et al., 1985; Szendrei et al., tangles of Alzheimer's disease. Neuron 3, 519±526.
1993); mAb PHF1 (Greenberg and Davies, 1990; Lang et al., 1992;
Goedert, M., Jakes, R., Crowther, R.A., Six, J., Lubke, U., Vander-
Otvos et al., 1994); mAb PHF6 (Hoffmann et al., 1997); mAb AT8
meeren, M., Cras, P., Trojanowski, J.Q., and Lee, V.M.-Y. (1993).
(Goedert et al., 1993, 1994); mAb AT270 (Goedert et al., 1994; Matsuo
The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer
et al., 1994); mAb 12E8 (Seubert et al., 1995); and polyclonal rabbit
disease recapitulates phosphorylation during development. Proc.
antiserum T3P (Lee et al., 1991). Antibodies against NF subunits
Natl. Acad. Sci. USA 90, 5066±5070.
included mAb RMdO9 (nonphosphorylated NFH), mAb RMO55
Goedert, M., Jakes, R., Crowther, R.A., Cohen, P., Vanmechelen,(phosphorylated NFM), rat mAb TA51 (phosphorylated NFH and
E., Vandermeeren, M., and Cras, P. (1994). Epitope mapping ofNFM), and polyclonal rabbit antiserum to NFL (Tu et al., 1995). In
monoclonal antibodies to the paired helical filaments of Alzheimer'saddition, a rat mAb to a-tubulin and a mouse mAb to b-tubulin were
disease: identification of phosphorylation sites in tau protein. Bio-purchased, and a rat mAb (2.2B10) to GFAP (Tu et al., 1995) was
chem. J. 301, 871±877.also used.
Goedert, M., Trojanowski, J.Q., and Lee, V.M.-Y. (1997). The neurofi-
brillary pathology of Alzheimer's disease. In The Molecular and Ge-Acknowledgments
netic Basis of Neurological Diseases. S.B. Prusiner et al., eds. (Bos-
ton: Butterworth-Heinemann Press), pp. 613±627.We thank Dr. A. Hirano for providing tissue block of ALS/PDC; the
Biomedical Imaging Core Facility of the University of Pennsylvania Goetz, J., Probst, A., Spillantini, M.G., Schafer, T., Jakes, R., Buerki,
K., and Goedert, M. (1995). Somatodendritic localization and hyper-for assistance in the EM studies; Dr. M. L. Schmidt for PSP and
FTDP-17 sections; and N. Shah, E. Heatherby, K. H. Szymczyk, and phosphorylation of tau protein in transgenic mice expressing the
longest human brain tau isoform. EMBO J. 14, 1304±1313.Grace Kim for technical assistance. This work was supported by
grants from the National Institute on Aging. Greenberg, S.G., and Davies, P. (1990). A preparation of Alzheimer
paired helical filaments that displays distinct tau proteins by poly-
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